Chatur S, Vaduganathan M, Fletcher RA, Perkovic V, et al. Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant-level pooled analysis of the CANVAS and CREDENCE trials. Eur J Heart Fail 2025;27:994-1002.
PMID: 39844714